Phase I Study of RiMO-401 With Radiation in Advanced Tumors
Coordination Pharmaceuticals, Inc.
Coordination Pharmaceuticals, Inc.
Candel Therapeutics, Inc.
Basilea Pharmaceutica
OX2 Therapeutics
Adaptimmune
Candel Therapeutics, Inc.
Pfizer
EpicentRx, Inc.
Boston Scientific Corporation
Cavion
Oncolys BioPharma Inc
AbbVie
Sanofi
AstraZeneca